Clinical Evaluation of Patients With X-linked Retinoschisis

X-linked Retinoschisis Clinical Trial

Official title:
Clinical Evaluation of Patients With X-linked Retinoschisis (XLRS)

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate subjects with X-linked retinoschisis in a clinical setting to collect data on disease progression.

Clinical Trial Description

The objective of the study is to evaluate subjects with XLRS in a clinical setting and gather data on disease progression. The data from this study will enhance the understanding of the natural history of this rare disease and will facilitate appropriately powered safety studies in a future gene therapy trial in humans. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02331173
Study type	Observational
Source	Applied Genetic Technologies Corp
Contact
Status	Completed
Phase	N/A
Start date	November 2012
Completion date	October 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06066008` - Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients	Early Phase 1
Completed	`NCT02416622` - Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)	Phase 1/Phase 2
Recruiting	`NCT05814952` - Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)	N/A
Recruiting	`NCT05878860` - ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis	Phase 1/Phase 2